Shifu Tang

1.0k total citations
25 papers, 766 citations indexed

About

Shifu Tang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shifu Tang has authored 25 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Shifu Tang's work include Cancer, Hypoxia, and Metabolism (4 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Shifu Tang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Shifu Tang collaborates with scholars based in China, United States and United Kingdom. Shifu Tang's co-authors include Manran Liu, Xi Tang, Yixuan Hou, Xiaojiang Cui, Hailong Zhang, Siyang Wen, Liyun Xu, Gang Tu, Yan-e Du and Mingli Zhou and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stem Cells.

In The Last Decade

Shifu Tang

24 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shifu Tang China 13 505 382 215 68 62 25 766
Yan-qing Ding China 18 456 0.9× 172 0.5× 188 0.9× 38 0.6× 77 1.2× 71 747
Xiaobo Cui China 18 574 1.1× 319 0.8× 210 1.0× 45 0.7× 55 0.9× 49 864
Wen‐Cheng Chou Taiwan 13 441 0.9× 182 0.5× 179 0.8× 64 0.9× 29 0.5× 25 625
Parker L. Sulkowski United States 9 487 1.0× 211 0.6× 122 0.6× 79 1.2× 27 0.4× 10 681
Qing Shao China 14 484 1.0× 320 0.8× 121 0.6× 38 0.6× 41 0.7× 30 778
Aswin Abraham Canada 11 376 0.7× 136 0.4× 205 1.0× 39 0.6× 72 1.2× 30 718
Silvia Ottaviani United Kingdom 15 442 0.9× 286 0.7× 217 1.0× 39 0.6× 98 1.6× 28 843
Beibei Liu China 13 477 0.9× 225 0.6× 164 0.8× 38 0.6× 79 1.3× 46 711

Countries citing papers authored by Shifu Tang

Since Specialization
Citations

This map shows the geographic impact of Shifu Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifu Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifu Tang more than expected).

Fields of papers citing papers by Shifu Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shifu Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifu Tang. The network helps show where Shifu Tang may publish in the future.

Co-authorship network of co-authors of Shifu Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Shifu Tang. A scholar is included among the top collaborators of Shifu Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifu Tang. Shifu Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Yaoming, et al.. (2022). Tumor-derived miRNAs as tumor microenvironment regulators for synergistic therapeutic options. Journal of Cancer Research and Clinical Oncology. 149(1). 423–439. 3 indexed citations
2.
Li, Xing, Wan-Ping Wang, Weiji Wang, et al.. (2022). The Drosha-Independent MicroRNA6778-5p/GSK3β Axis Mediates the Proliferation of Gastric Cancer Cells. Computational Intelligence and Neuroscience. 2022. 1–7. 1 indexed citations
3.
Huang, Wenjie, et al.. (2021). Diagnostic Value of Serum DNASE1L3 in Hepatitis B Virus-Related Hepatocellular Carcinoma. Clinical Laboratory. 67(03/2021). 4 indexed citations
4.
Zhang, Hongyu, et al.. (2020). Clinical application of red cell distribution width, mean platelet volume, and cancer antigen 125 detection in endometrial cancer. Journal of Clinical Laboratory Analysis. 34(8). e23309–e23309. 10 indexed citations
5.
Yin, Kun, et al.. (2020). Application Prospects of Virtual Autopsy in Forensic Pathological Investigations on COVID-19.. SHILAP Revista de lepidopterología. 36(2). 149–156. 23 indexed citations
6.
Sun, Kexin, Shifu Tang, Yixuan Hou, et al.. (2019). Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling. EBioMedicine. 41. 370–383. 104 indexed citations
7.
Tang, Yinghua, et al.. (2017). Application of molecular, microbiological, and immunological tests for the diagnosis of bone and joint tuberculosis. Journal of Clinical Laboratory Analysis. 32(2). 17 indexed citations
8.
Sun, Yifan, et al.. (2016). Association of Interferon Gamma +874T/A Polymorphism and Leukemia Risk. Medicine. 95(12). e3129–e3129. 5 indexed citations
9.
Tang, Shifu, Lili Wei, Yifan Sun, et al.. (2016). CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis. PLoS ONE. 11(9). e0163030–e0163030. 22 indexed citations
10.
11.
Zhou, Mingli, Yixuan Hou, Guanglun Yang, et al.. (2015). LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway. Stem Cells. 34(1). 55–66. 145 indexed citations
12.
Yu, Tenghua, Manran Liu, Haojun Luo, et al.. (2014). GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 143. 392–403. 70 indexed citations
13.
Zeng, Zongyue, Jiangen Wang, Liuyang Zhao, et al.. (2013). Potential Role of microRNA-21 in the Diagnosis of Gastric Cancer: A Meta-Analysis. PLoS ONE. 8(9). e73278–e73278. 54 indexed citations
14.
Hu, Weiwei, Feng Jiang, Shifu Tang, et al.. (2013). Association between KCNQ1 genetic variants and QT interval in a Chinese population. Diabetic Medicine. 30(10). 1225–1229. 2 indexed citations
15.
Xing, Xiumei, Caixia Liu, Shifu Tang, et al.. (2012). DNA repair gene deficiency does not predispose human bronchial epithelial cells to benzo(a)pyrene-induced cell transformation. Toxicology in Vitro. 26(4). 579–584. 4 indexed citations
16.
Yu, Weihui, Cheng Hu, Wen Qin, et al.. (2011). Effects of KCNQ1 Polymorphisms on the Therapeutic Efficacy of Oral Antidiabetic Drugs in Chinese Patients With Type 2 Diabetes. Clinical Pharmacology & Therapeutics. 89(3). 437–442. 31 indexed citations
17.
Xiao, Yongmei, Wenxue Li, Rulin Ma, et al.. (2009). [Metabolic activation of benzo(a)pyrene enhanced transformation of human bronchial epithelium cell HBETR].. PubMed. 38(6). 645–8. 2 indexed citations
18.
Li, Wenxue, Rulin Ma, Weidong Ji, et al.. (2008). Development of human cell models for assessing the carcinogenic potential of chemicals. Toxicology and Applied Pharmacology. 232(3). 478–486. 30 indexed citations
19.
Ma, Rulin, Wenxue Li, Yongmei Xiao, et al.. (2008). [Establishment and application of oncogene over expressed human epithelial cell transformation model].. PubMed. 42(6). 395–9.
20.
Tang, Shifu, et al.. (1994). Effects of toosendanin on electric and mechanical properties of guinea pig papillary muscles.. PubMed. 15(2). 147–51. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026